Fijn R - Search Results

1

Introducing ethics in hospital drug resource allocation decisions: keep expectations modest and beware of unintended effects. Part I: An explorative overview.

Fijn R, van Epenhuysen LS, Peijnenburg AJ, de Jong-van den Berg LT, Brouwers JR. Fijn R, et al. Pharmacoepidemiol Drug Saf. 2002 Sep;11(6):523-7. doi: 10.1002/pds.751. Pharmacoepidemiol Drug Saf. 2002. PMID: 12426938 Review. No abstract available.

2

Is there a need for critical ethical and philosophical evaluation of hospital drugs and therapeutics (D&T) committees?

Fijn R, van Epenhuysen LS, Peijnenburg AJ, Brouwers JR, de Jong-van den Berg LT. Fijn R, et al. Pharmacoepidemiol Drug Saf. 2002 Apr-May;11(3):247-52. doi: 10.1002/pds.719. Pharmacoepidemiol Drug Saf. 2002. PMID: 12058711 No abstract available.

3

Multicentre evaluation of prescribing concurrence with anti-infective guidelines: epidemiological assessment of indicators.

Fijn R, Chow MC, Schuur PM, De Jong-Van den Berg LT, Brouwers JR. Fijn R, et al. Pharmacoepidemiol Drug Saf. 2002 Jul-Aug;11(5):361-72. doi: 10.1002/pds.723. Pharmacoepidemiol Drug Saf. 2002. PMID: 12271877

4

Introducing ethics in hospital drug resource allocation decisions: keep expectations modest and beware of unintended effects. Part II: The use of ethics.

Fijn R, van Epenhuysen LS, Peijnenburg AJ, de Jong-van den Berg LT, Brouwers JR. Fijn R, et al. Pharmacoepidemiol Drug Saf. 2002 Oct-Nov;11(7):617-20. doi: 10.1002/pds.780. Pharmacoepidemiol Drug Saf. 2002. PMID: 12462141 No abstract available.

5

Cost-benefit analysis of the detection of prescribing errors by hospital pharmacy staff.

van den Bemt PM, Postma MJ, van Roon EN, Chow MC, Fijn R, Brouwers JR. van den Bemt PM, et al. Among authors: fijn r. Drug Saf. 2002;25(2):135-43. doi: 10.2165/00002018-200225020-00006. Drug Saf. 2002. PMID: 11888354

6

Dutch hospital drug formularies: pharmacotherapeutic variation and conservatism, but concurrence with national pharmacotherapeutic guidelines.

Fijn R, Engels SA, Brouwers JR, Knaap RJ, De Jong-Van den Berg LT. Fijn R, et al. Br J Clin Pharmacol. 2000 Mar;49(3):254-63. doi: 10.1046/j.1365-2125.2000.00166.x. Br J Clin Pharmacol. 2000. PMID: 10718781 Free PMC article.

7

Assessment of indicators for hospital drug formulary non-adherence.

Fijn R, Lenderink AW, Egberts AC, Brouwers JR, De Jong-Van DenBerg LT. Fijn R, et al. Eur J Clin Pharmacol. 2001 Nov;57(9):677-84. doi: 10.1007/s002280100358. Eur J Clin Pharmacol. 2001. PMID: 11791899

8

Hospital prescribing errors: epidemiological assessment of predictors.

Fijn R, Van den Bemt PM, Chow M, De Blaey CJ, De Jong-Van den Berg LT, Brouwers JR. Fijn R, et al. Br J Clin Pharmacol. 2002 Mar;53(3):326-31. doi: 10.1046/j.0306-5251.2001.bjcp1558.doc.x. Br J Clin Pharmacol. 2002. PMID: 11874397 Free PMC article.

9

Prevention of heterotopic ossification after total hip replacement with NSAIDs.

Fijn R, Koorevaar RT, Brouwers JR. Fijn R, et al. Pharm World Sci. 2003 Aug;25(4):138-45. doi: 10.1023/a:1024830213832. Pharm World Sci. 2003. PMID: 12964491 Review.

10

Rational pharmacotherapy in The Netherlands: formulary management in Dutch hospitals.

Fijn R, de Jong-van den Berg LT, Brouwers JR. Fijn R, et al. Pharm World Sci. 1999 Apr;21(2):74-9. doi: 10.1023/a:1008654609916. Pharm World Sci. 1999. PMID: 10380234

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters